|
1
|
Rizvi S and Gores GJ: Pathogenesis,
diagnosis, and management of cholangiocarcinoma. Gastroenterology.
145:1215–1229. 2013. View Article : Google Scholar
|
|
2
|
Cardinale V: Classifications and
misclassification in cholangiocarcinoma. Liver Int. 39:260–262.
2019. View Article : Google Scholar
|
|
3
|
Brindley PJ, Bachini M, Ilyas SI, Khan SA,
Loukas A, Sirica AE, The BT, Wongkham S and Gores GJ:
Cholangiocarcinoma. Nat Rev Dis Primers. 7:652021. View Article : Google Scholar
|
|
4
|
Sripa B, Suwannatrai AT, Sayasone S, Do
DT, Khieu V and Yang Y: Current status of human liver fluke
infections in the Greater Mekong Subregion. Acta Trop.
224:1061332021. View Article : Google Scholar
|
|
5
|
Qurashi M, Vithayathil M and Khan SA:
Epidemiology of cholangiocarcinoma. Eur J Surg Oncol. 9:1070642023.
View Article : Google Scholar
|
|
6
|
Kim R, Taylor D, Vonderheide RH and
Gabrilovich DI: Ferroptosis of immune cells in the tumor
microenvironment. Trends Pharmacol Sci. 44:542–552. 2023.
View Article : Google Scholar
|
|
7
|
Xu Y, Xing Z, Suliman RAI, Liu Z and Tang
F: Ferroptosis in liver cancer: A key role of post-translational
modifications. Front Immunol. 15:13755892024. View Article : Google Scholar
|
|
8
|
Zhou TJ, Zhang MM, Liu DM, Huang LL, Yu
HQ, Wang Y, Xing L and Jiang HL: Glutathione depletion and
dihydroorotate dehydrogenase inhibition actuated
ferroptosis-augment to surmount triple-negative breast cancer.
Biomaterials. 305:1224472024. View Article : Google Scholar
|
|
9
|
Deng J, Lin X, Qin J, Li Q, Zhang Y, Zhang
Q, Ji C, Shen S, Li Y, Zhang B and Lin N: SPTBN2 suppresses
ferroptosis in NSCLC cells by facilitating SLC7A11 membrane
trafficking and localization. Redox Biol. 70:1030392024. View Article : Google Scholar
|
|
10
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012. View Article : Google Scholar
|
|
11
|
Nakamura T, Naguro I and Ichijo H: Iron
homeostasis and iron-regulated ROS in cell death, senescence and
human diseases. Biochim Biophys Acta Gen Subj. 1863:1398–1409.
2019. View Article : Google Scholar
|
|
12
|
D'Arcy MS: Cell death: A review of the
major forms of apoptosis, necrosis and autophagy. Cell Biol Int.
43:582–592. 2019. View Article : Google Scholar
|
|
13
|
Fu C, Cao N, Zeng S, Zhu W, Fu X, Liu W
and Fan S: Role of mitochondria in the regulation of ferroptosis
and disease. Front Med (Lausanne). 10:13018222023. View Article : Google Scholar
|
|
14
|
Otasevic V, Vucetic M, Grigorov I,
Martinovic V and Stancic A: Ferroptosis in different pathological
contexts seen through the eyes of mitochondria. Oxid Med Cell
Longev. 2021:55373302021. View Article : Google Scholar
|
|
15
|
Xie LH, Fefelova N, Pamarthi SH and
Gwathmey JK: Molecular mechanisms of ferroptosis and relevance to
cardiovascular disease. Cells. 11:27262022. View Article : Google Scholar
|
|
16
|
Liu J, Kang R and Tang D: Signaling
pathways and defense mechanisms of ferroptosis. FEBS J.
289:7038–7050. 2022. View Article : Google Scholar
|
|
17
|
Liu T, Zhang L, Joo D and Sun SC: NF-κB
signaling in inflammation. Signal Transduct Target Ther.
2:170232017. View Article : Google Scholar
|
|
18
|
Ahmad A and Ahsan H: Biomarkers of
inflammation and oxidative stress in ophthalmic disorders. J
Immunoassay Immunochem. 41:257–271. 2020. View Article : Google Scholar
|
|
19
|
Yang W, Wang Y, Zhang C, Huang Y, Yu J,
Shi L, Zhang P, Yin Y, Li R and Tao K: Maresin1 protect against
ferroptosis-induced liver injury through ROS inhibition and
Nrf2/HO-1/GPX4 activation. Front Pharmacol. 13:8656892022.
View Article : Google Scholar
|
|
20
|
Tanase DM, Gosav EM, Anton MI, Floria M,
Isac PN, Hurjui LL, Tarniceriu CC, Costea CF, Ciocoiu M and Rezus
C: Oxidative stress and NRF2/KEAP1/ARE pathway in diabetic kidney
disease (DKD): New perspectives. Biomolecules. 12:12272022.
View Article : Google Scholar
|
|
21
|
Ueda N and Takasawa K: Impact of
inflammation on ferritin, hepcidin and the management of iron
deficiency anemia in chronic kidney disease. Nutrients.
10:11732018. View Article : Google Scholar
|
|
22
|
Chen Y, Fang ZM, Yi X, Wei X and Jiang DS:
The interaction between ferroptosis and inflammatory signaling
pathways. Cell Death Dis. 14:2052023. View Article : Google Scholar
|
|
23
|
Schmitt A, Xu W, Bucher P, Grimm M,
Konantz M, Horn H, Zapukhlyak M, Berning P, Brändle M, Jarboui MA,
et al: Dimethyl fumarate induces ferroptosis and impairs NF-κ/STAT3
signaling in DLBCL. Blood. 138:871–884. 2021. View Article : Google Scholar
|
|
24
|
Yan N, Xu Z, Qu C and Zhang J: Dimethyl
fumarate improves cognitive deficits in chronic cerebral
hypoperfusion rats by alleviating inflammation, oxidative stress,
and ferroptosis via NRF2/ARE/NF-κB signal pathway. Int
Immunopharmacol. 98:1078442021. View Article : Google Scholar
|
|
25
|
Zhao C, Xiao C, Feng S and Bai J:
Artemisitene alters LPS-induced oxidative stress, inflammation and
ferroptosis in liver through Nrf2/HO-1 and NF-kB pathway. Front
Pharmacol. 14:11775422023. View Article : Google Scholar
|
|
26
|
Yeung YT, Aziz F, Guerrero-Castilla A and
Arguelles S: Signaling pathways in inflammation and
anti-inflammatory therapies. Curr Pharm Des. 24:1449–1484. 2018.
View Article : Google Scholar
|
|
27
|
Xu X, Mao C, Zhang C, Zhang M, Gong J and
Wang X: Salvianolic Acid B inhibits ferroptosis and apoptosis
during myocardial ischemia/reperfusion injury via decreasing the
ubiquitin-proteasome degradation of GPX4 and the ROS-JNK/MAPK
pathways. Molecules. 28:41172023. View Article : Google Scholar
|
|
28
|
Lu JS, Wang JH, Han K and Li N: Nicorandil
regulates ferroptosis and mitigates septic cardiomyopathy via
TLR4/SLC7A11 signaling pathway. Inflammation. 47:975–988. 2024.
View Article : Google Scholar
|
|
29
|
Zhu K, Zhu X, Sun S, Yang W, Liu S, Tang
Z, Zhang R, Li J, Shen T and Hei M: Inhibition of TLR4 prevents
hippocampal hypoxic-ischemic injury by regulating ferroptosis in
neonatal rats. Exp Neurol. 345:1138282021. View Article : Google Scholar
|
|
30
|
Cardoso-Pires C and Vieira HLA: Carbon
monoxide and mitochondria: Cell energy and fate control. Biochim
Biophys Acta Mol Basis Dis. 1870:1674462024. View Article : Google Scholar
|
|
31
|
Du L, Guo C, Zeng S, Yu K, Liu M and Li Y:
Sirt6 overexpression relieves ferroptosis and delays the
progression of diabetic nephropathy via Nrf2/GPX4 pathway. Ren
Fail. 46:23777852024. View Article : Google Scholar
|
|
32
|
Sun K, Zhi Y, Ren W, Li S, Zhou X, Gao L
and Zhi K: The mitochondrial regulation in ferroptosis signaling
pathway and its potential strategies for cancer. Biomed
Pharmacother. 169:1158922023. View Article : Google Scholar
|
|
33
|
Murphy MP: How mitochondria produce
reactive oxygen species. Biochem J. 417:1–13. 2009. View Article : Google Scholar
|
|
34
|
Su D, Ding C, Wang R, Qiu J, Liu Y, Tao J,
Luo W, Weng G, Yang G and Zhang T: E3 ubiquitin ligase RBCK1
confers ferroptosis resistance in pancreatic cancer by facilitating
MFN2 degradation. Free Radic Biol Med. 221:136–154. 2024.
View Article : Google Scholar
|
|
35
|
Zheng J and Conrad M: The metabolic
underpinnings of ferroptosis. Cell Metab. 32:920–937. 2020.
View Article : Google Scholar
|
|
36
|
Xiang Q, Wen J, Zhou Z, Dai Q, Huang Y,
Yang N, Guo J, Zhang J, Ren F, Zhou X, et al: Effect of
hydroxy-α-sanshool on lipid metabolism in liver and hepatocytes
based on AMPK signaling pathway. Phytomedicine. 132:1558492024.
View Article : Google Scholar
|
|
37
|
Copur S, Yildiz AB, Covic A and Kanbay M:
Is there any robust evidence showing that SGLT2 inhibitor
predisposes to cancer? Eur J Clin Invest. 54:e141312024. View Article : Google Scholar
|
|
38
|
Gao M, Yi J, Zhu J, Minikes AM, Monian P,
Thompson CB and Jiang X: Role of mitochondria in ferroptosis. Mol
Cell. 73:354–363. e3532019. View Article : Google Scholar
|
|
39
|
Qi Y, Zheng J, Zi Y, Song W, Chen X, Cao
S, Zhou Q, Fu H and Hu X: Loureirin C improves mitochondrial
function by promoting NRF2 nuclear translocation to attenuate
oxidative damage caused by renal ischemia-reperfusion injury. Int
Immunopharmacol. 138:1125962024. View Article : Google Scholar
|
|
40
|
Zhang T, Jing M, Fei L, Zhang Z, Yi P, Sun
Y and Wang Y: Tetramethylpyrazine nitrone delays the aging process
of C. elegans by improving mitochondrial function through the
AMPK/mTORC1 signaling pathway. Biochem Biophys Res Commun.
723:1502202024. View Article : Google Scholar
|
|
41
|
Lane DJR, Metselaar B, Greenough M, Bush
AI and Ayton SJ: Ferroptosis and NRF2: An emerging battlefield in
the neurodegeneration of Alzheimer's disease. Essays Biochem.
65:925–940. 2021. View Article : Google Scholar
|
|
42
|
Zhang JY, Meng X, Zhu XL, Peng SR, Li HB,
Mo HZ and Hu LB: Thymol induces fenton-reaction-dependent
ferroptosis in vibrio parahemolyticus. J Agric Food Chem.
72:14337–14348. 2024. View Article : Google Scholar
|
|
43
|
Torti SV and Torti FM: Iron and cancer:
More ore to be mined. Nat Rev Cancer. 13:342–355. 2013. View Article : Google Scholar
|
|
44
|
Zhang C: Essential functions of
iron-requiring proteins in DNA replication, repair and cell cycle
control. Protein Cell. 5:750–760. 2014. View Article : Google Scholar
|
|
45
|
Koppenol WH and Hider RH: Iron and redox
cycling. Do's and don'ts. Free Radic Biol Med. 133:3–10. 2019.
View Article : Google Scholar
|
|
46
|
Xu L, Liu Y, Chen X, Zhong H and Wang Y:
Ferroptosis in life: To be or not to be. Biomed Pharmacother.
159:1142412023. View Article : Google Scholar
|
|
47
|
Hassannia B, Vandenabeele P and Berghe TV:
Targeting ferroptosis to iron out cancer. Cancer Cell. 35:830–849.
2019. View Article : Google Scholar
|
|
48
|
Fang X, Ardehali H, Min J and Wang F: The
molecular and metabolic landscape of iron and ferroptosis in
cardiovascular disease. Nat Rev Cardiol. 20:7–23. 2023. View Article : Google Scholar
|
|
49
|
Truman-Rosentsvit M, Berenbaum D, Spektor
L, Cohen LA, Belizowsky-Moshe S, Lifshitz L, Ma J, Li W, Kesselman
E, Abutbul-Ionita I, et al: Ferritin is secreted via 2 distinct
nonclassical vesicular pathways. Blood. 131:342–352. 2018.
View Article : Google Scholar
|
|
50
|
Rochette L, Dogon G, Rigal E, Zeller M,
Cottin Y and Vergely C: Lipid peroxidation and iron metabolism: Two
corner stones in the homeostasis control of ferroptosis. Int J Mol
Sci. 24:4492022. View Article : Google Scholar
|
|
51
|
Chen X, Yu C, Kang R and Tang D: Iron
metabolism in ferroptosis. Front Cell Dev Biol. 8:5902262020.
View Article : Google Scholar
|
|
52
|
Yu X, Guo Q, Zhang H, Wang X, Han Y and
Yang Z: Hypoxia-inducible factor-1alpha can reverse the Adriamycin
resistance of breast cancer adjuvant chemotherapy by upregulating
transferrin receptor and activating ferroptosis. FASEB J.
38:e238762024. View Article : Google Scholar
|
|
53
|
Sies H: Oxidative stress: A concept in
redox biology and medicine. Redox Biol. 4:180–183. 2015. View Article : Google Scholar
|
|
54
|
Chen S, Li Q, Shi H, Li F, Duan Y and Guo
Q: New insights into the role of mitochondrial dynamics in
oxidative stress-induced diseases. Biomed Pharmacother.
178:1170842024. View Article : Google Scholar
|
|
55
|
Jomova K, Raptova R, Alomar SY, Alwasel
SH, Nepovimova E, Kuca K and Valko M: Reactive oxygen species,
toxicity, oxidative stress, and antioxidants: Chronic diseases and
aging. Arch Toxicol. 97:2499–2574. 2023. View Article : Google Scholar
|
|
56
|
Galaris D, Barbouti A and Pantopoulos K:
Iron homeostasis and oxidative stress: An intimate relationship.
Biochim Biophys Acta Mol Cell Res. 1866:1185352019. View Article : Google Scholar
|
|
57
|
Carocci A, Catalano A, Sinicropi MS and
Genchi G: Oxidative stress and neurodegeneration: The involvement
of iron. Biometals. 31:715–735. 2018. View Article : Google Scholar
|
|
58
|
Boldyreva LV, Morozova MV, Saydakova SS
and Kozhevnikova EN: Fat of the gut: Epithelial phospholipids in
inflammatory bowel diseases. Int J Mol Sci. 22:116822021.
View Article : Google Scholar
|
|
59
|
Feng H and Stockwell BR: Unsolved
mysteries: How does lipid peroxidation cause ferroptosis? PLoS
Biol. 16:e20062032018. View Article : Google Scholar
|
|
60
|
Liang D, Minikes AM and Jiang X:
Ferroptosis at the intersection of lipid metabolism and cellular
signaling. Mol Cell. 82:2215–2227. 2022. View Article : Google Scholar
|
|
61
|
Li FJ, Long HZ, Zhou ZW, Luo HY, Xu SG and
Gao LC: System X(c) (−)/GSH/GPX4 axis: An important antioxidant
system for the ferroptosis in drug-resistant solid tumor therapy.
Front Pharmacol. 13:9102922022. View Article : Google Scholar
|
|
62
|
Hussain S, Gupta G, Shahwan M, Bansal P,
Kaur H, Deorari M, Pant K, Ali H, Singh SK, Allam VS, et al:
Non-coding RNA: A key regulator in the Glutathione-GPX4 pathway of
ferroptosis. Noncoding RNA Res. 9:1222–1234. 2024. View Article : Google Scholar
|
|
63
|
Xie Y, Kang R, Klionsky DJ and Tang D:
GPX4 in cell death, autophagy, and disease. Autophagy.
19:2621–2638. 2023. View Article : Google Scholar
|
|
64
|
Liu Y, Wan Y, Jiang Y, Zhang L and Cheng
W: GPX4: The hub of lipid oxidation, ferroptosis, disease and
treatment. Biochim Biophys Acta Rev Cancer. 1878:1888902023.
View Article : Google Scholar
|
|
65
|
Liu Y, Lu S, Wu LL, Yang L, Yang L and
Wang J: The diversified role of mitochondria in ferroptosis in
cancer. Cell Death Dis. 14:5192023. View Article : Google Scholar
|
|
66
|
Jiang X, Stockwell BR and Conrad M:
Ferroptosis: Mechanisms, biology and role in disease. Nat Rev Mol
Cell Biol. 22:266–282. 2021. View Article : Google Scholar
|
|
67
|
Dodson M, Castro-Portuguez R and Zhang DD:
NRF2 plays a critical role in mitigating lipid peroxidation and
ferroptosis. Redox Biol. 23:1011072019. View Article : Google Scholar
|
|
68
|
Liu Y, Su Z, Tavana O and Gu W:
Understanding the complexity of p53 in a new era of tumor
suppression. Cancer Cell. 42:946–967. 2024. View Article : Google Scholar
|
|
69
|
Shin D, Lee J and Roh JL: Pioneering the
future of cancer therapy: Deciphering the p53-ferroptosis nexus for
precision medicine. Cancer Lett. 585:2166452024. View Article : Google Scholar
|
|
70
|
Hu H, Zhang G, Tian M, Yin Y, Bao Y, Guan
X, Ding C and Yu S: Brucella rough RB51 infection activates
P53-Slc7a11-Gpx4/GSH pathway to induce ferroptosis to attenuate the
intracellular survival on macrophages. Vet Microbiol.
298:1102242024. View Article : Google Scholar
|
|
71
|
Liao W, Zhang R, Chen G, Zhu X, Wu W, Chen
Z, Jiang C, Lin Z, Ma L and Yu H: Berberine synergises with
ferroptosis inducer sensitizing NSCLC to ferroptosis in
p53-dependent SLC7A11-GPX4 pathway. Biomed Pharmacother.
176:1168322024. View Article : Google Scholar
|
|
72
|
Fu R, You Y, Wang Y, Wang J, Lu Y, Gao R,
Pang M, Yang P and Wang H: Sanggenol L induces ferroptosis in
non-small cell lung cancer cells via regulating the
miR-26a-1-3p/MDM2/p53 signaling pathway. Biochem Pharmacol.
226:1163452024. View Article : Google Scholar
|
|
73
|
Zeng C, Xiong D, Zhang K and Yao J:
Shank-associated RH domain interactor signaling in tumorigenesis.
Oncol Lett. 20:2579–2586. 2020. View Article : Google Scholar
|
|
74
|
Zeng C, Lin J, Zhang K, Ou H, Shen K, Liu
Q, Wei Z, Dong X, Zeng X, Zeng L, et al: SHARPIN promotes cell
proliferation of cholangiocarcinoma and inhibits ferroptosis via
p53/SLC7A11/GPX4 signaling. Cancer Sci. 113:3766–3775. 2022.
View Article : Google Scholar
|
|
75
|
Chu B, Kon N, Chen D, Li T, Liu T, Jiang
L, Song S, Tavana O and Gu W: ALOX12 is required for p53-mediated
tumour suppression through a distinct ferroptosis pathway. Nat Cell
Biol. 21:579–591. 2019. View Article : Google Scholar
|
|
76
|
Ou Y, Wang SJ, Li D, Chu B and Gu W:
Activation of SAT1 engages polyamine metabolism with p53-mediated
ferroptotic responses. Proc Natl Acad Sci USA. 113:E6806–E6812.
2016. View Article : Google Scholar
|
|
77
|
Lu B, Christensen IT, Yu T, Wang C, Yan Q
and Wang X: SUMOylation evoked by oxidative stress reduced lens
epithelial cell antioxidant functions by increasing the stability
and transcription of TP53INP1 in age-related cataracts. Oxid Med
Cell Longev. 2019:78980692019. View Article : Google Scholar
|
|
78
|
Wang J, Yi H, Li J, Yang Y, Sun G, Xue Y
and He L: P62-autophagic pathway degrades SLC7A11 to regulate
ferroptosis in doxorubicin-induced cardiotoxicity. Life Sci.
356:1229812024. View Article : Google Scholar
|
|
79
|
Lin Z, Wu C, Song D, Zhu C, Wu B, Wang J
and Xue Y: Sarmentosin alleviates doxorubicin-induced
cardiotoxicity and ferroptosis via the p62-Keap1-Nrf2 pathway.
Redox Rep. 29:23923292024. View Article : Google Scholar
|
|
80
|
Zhao Y, Lu J, Mao A, Zhang R and Guan S:
Autophagy inhibition plays a protective role in ferroptosis induced
by alcohol via the p62-Keap1-Nrf2 Pathway. J Agric Food Chem.
69:9671–9683. 2021. View Article : Google Scholar
|
|
81
|
Zhou Y, Yang Y, Yi L, Pan M, Tang W and
Duan H: Propofol mitigates sepsis-induced brain injury by
inhibiting ferroptosis via activation of the Nrf2/HO-1axis.
Neurochem Res. 49:2131–2147. 2024. View Article : Google Scholar
|
|
82
|
Liu N, Wu WL, Wan XR, Wang J, Huang JN,
Jiang YY, Sheng YC, Wu JC, Liang ZQ, Qin ZH and Wang Y: Regulation
of FSP1 myristoylation by NADPH: A novel mechanism for ferroptosis
inhibition. Redox Biol. 73:1031762024. View Article : Google Scholar
|
|
83
|
Dai E, Zhang W, Cong D, Kang R, Wang J and
Tang D: AIFM2 blocks ferroptosis independent of ubiquinol
metabolism. Biochem Biophys Res Commun. 523:966–971. 2020.
View Article : Google Scholar
|
|
84
|
Guo J, Chen L and Ma M: Ginsenoside Rg1
suppresses ferroptosis of renal tubular epithelial cells in
sepsis-induced acute kidney injury via the FSP1-CoQ(10)- NAD(P)H
pathway. Curr Med Chem. 31:2119–2132. 2024. View Article : Google Scholar
|
|
85
|
Li D and Li Y: The interaction between
ferroptosis and lipid metabolism in cancer. Signal Transduct Target
Ther. 5:1082020. View Article : Google Scholar
|
|
86
|
Torti SV and Torti FM: Iron and cancer:
2020 vision. Cancer Res. 80:5435–5448. 2020. View Article : Google Scholar
|
|
87
|
Toshida K, Itoh S, Iseda N, Izumi T, Bekki
Y, Yoshiya S, Toshima T, Iwasaki T, Oda Y and Yoshizumi T: The
association of transferrin receptor with prognosis and biologic
role in intrahepatic cholangiocarcinoma. Ann Surg Oncol.
23:10.1245/s10434–024-16065-3. 2024.
|
|
88
|
Vogt AS, Arsiwala T, Mohsen M, Vogel M,
Manolova V and Bachmann MF: On iron metabolism and its regulation.
Int J Mol Sci. 22:45912021. View Article : Google Scholar
|
|
89
|
Guo W, Zhang S, Chen Y, Zhang D, Yuan L,
Cong H and Liu S: An important role of the hepcidin-ferroportin
signaling in affecting tumor growth and metastasis. Acta Biochim
Biophys Sin (Shanghai). 47:703–715. 2015. View Article : Google Scholar
|
|
90
|
Raggi C, Gammella E, Correnti M, Buratti
P, Forti E, Andersen JB, Alpini G, Glaser S, Alvaro D, Invernizzi
P, et al: Dysregulation of iron metabolism in cholangiocarcinoma
stem-like cells. Sci Rep. 7:176672017. View Article : Google Scholar
|
|
91
|
Kong L, Liu Y, Li J, Wang Y, Ji P, Shi Q,
Han M, Xu H and Li W and Li W: Ginsenoside Rg1 alleviates chronic
inflammation-induced neuronal ferroptosis and cognitive impairments
via regulation of AIM2-Nrf2 signaling pathway. J Ethnopharmacol.
330:1182052024. View Article : Google Scholar
|
|
92
|
Caligiuri A, Becatti M, Porro N, Borghi S,
Marra F, Pastore M, Taddei N, Fiorillo C and Gentilini A: Oxidative
stress and redox-dependent pathways in cholangiocarcinoma.
Antioxidants (Basel). 13:282023. View Article : Google Scholar
|
|
93
|
Thanan R, Oikawa S, Yongvanit P, Hiraku Y,
Ma N, Pinlaor S, Pairojkul C, Wongkham C, Sripa B, Khuntikeo N, et
al: Inflammation-induced protein carbonylation contributes to poor
prognosis for cholangiocarcinoma. Free Radic Biol Med.
52:1465–1472. 2012. View Article : Google Scholar
|
|
94
|
Nevi L, Di Matteo S, Carpino G, Zizzari
IG, Samira S, Ambrosino V, Costantini D, Overi D, Giancotti A,
Monti M, et al: DCLK1, a putative stem cell marker in human
cholangiocarcinoma. Hepatology. 73:144–159. 2021. View Article : Google Scholar
|
|
95
|
Takahashi Y, Dungubat E, Kusano H, Ganbat
D, Tomita Y, Odgerel S and Fukusato T: Application of
immunohistochemistry in the pathological diagnosis of liver tumors.
Int J Mol Sci. 22:57802021. View Article : Google Scholar
|
|
96
|
Voigtländer T, Metzger J, Husi H, Kirstein
MM, Pejchinovski M, Latosinska A, Frantzi M, Mullen W, Book T,
Mischak H and Manns MP: Bile and urine peptide marker profiles:
Access keys to molecular pathways and biological processes in
cholangiocarcinoma. J Biomed Sci. 27:132020. View Article : Google Scholar
|
|
97
|
Xin H, Zhang Y, Lai Q, Liao N, Zhang J,
Liu Y, Chen Z, He P, He J, Liu J, et al: Automatic origin
prediction of liver metastases via hierarchical
artificial-intelligence system trained on multiphasic CT data: A
retrospective, multicentre study. EClinicalMedicine. 69:1024642024.
View Article : Google Scholar
|
|
98
|
Yang Q, Cai Q, Wen H, Mao Y, Ban X, Rong D
and Zhang R: The CT and MRI features of primary intrahepatic
lymphoepithelioma-like cholangiocarcinoma. AJR Am J Roentgenol.
216:393–402. 2021. View Article : Google Scholar
|
|
99
|
Sae-Fung A, Mutirangura A and Jitkaew S:
Identification and validation of a novel ferroptosis -related gene
signature for prognosis and potential therapeutic target prediction
in cholangiocarcinoma. Front Immunol. 13:10512732022. View Article : Google Scholar
|
|
100
|
Bao F, Liu J, Chen H, Miao L, Xu Z and
Zhang G: Diagnosis biomarkers of cholangiocarcinoma in human bile:
An evidence-based study. Cancers (Basel). 14:39212022. View Article : Google Scholar
|
|
101
|
Lapitz A, Azkargorta M, Milkiewicz P,
Olaizola P, Zhuravleva E, Grimsrud MM, Schramm C, Arbelaiz A,
O'Rourke CJ, La Casta A, et al: Liquid biopsy-based protein
biomarkers for risk prediction, early diagnosis, and
prognostication of cholangiocarcinoma. J Hepatol. 79:93–108. 2023.
View Article : Google Scholar
|
|
102
|
El-Deiry WS, Goldberg RM, Lenz HJ, Shields
AF, Gibney GT, Tan AR, Brown J, Eisenberg B, Heath EI, Phuphanich
S, et al: The current state of molecular testing in the treatment
of patients with solid tumors, 2019. CA Cancer J Clin. 69:305–343.
2019. View Article : Google Scholar
|
|
103
|
Scott A, Wong P and Melstrom LG: Surgery
and hepatic artery infusion therapy for intrahepatic
cholangiocarcinoma. Surgery. 174:113–115. 2023. View Article : Google Scholar
|
|
104
|
Benson AB III, D'Angelica MI, Abrams TA,
Are C, Bloomston PM, Chang DT, Clary BM, Covey AM, Ensminger WD,
Iyer R, et al: Hepatobiliary cancers, version 2.2014. J Natl Compr
Canc Netw. 12:1152–1182. 2014. View Article : Google Scholar
|
|
105
|
Moris D, Palta M, Kim C, Allen PJ, Morse
MA and Lidsky ME: Advances in the treatment of intrahepatic
cholangiocarcinoma: An overview of the current and future
therapeutic landscape for clinicians. CA Cancer J Clin. 73:198–222.
2023. View Article : Google Scholar
|
|
106
|
Saito N, Hatanaka T, Nakano S, Hazama Y,
Yoshida S, Hachisu Y, Tanaka Y, Yoshinaga T, Kashiwabara K, Kubo N,
et al: A case of unresectable combined hepatocellular and
cholangiocarcinoma treated with atezolizumab plus bevacizumab. Clin
Case Rep. 10:e61292022. View Article : Google Scholar
|
|
107
|
Simon-Molas H, Sanchez-de-Diego C,
Navarro-Sabate A, Castaño E, Ventura F, Bartrons R and Manzano A:
The expression of TP53-induced glycolysis and apoptosis regulator
(TIGAR) can be controlled by the antioxidant orchestrator NRF2 in
human carcinoma cells. Int J Mol Sci. 23:19052022. View Article : Google Scholar
|
|
108
|
Toshida K, Itoh S, Iseda N, Izumi T,
Yoshiya S, Toshima T, Ninomiya M, Iwasaki T, Oda Y and Yoshizumi T:
Impact of TP53-induced glycolysis and apoptosis regulator on
malignant activity and resistance to ferroptosis in intrahepatic
cholangiocarcinoma. Cancer Sci. 115:170–183. 2024. View Article : Google Scholar
|
|
109
|
Shi Y, Gong M, Deng Z, Liu H, Chang Y,
Yang Z and Cai L: Tirapazamine suppress osteosarcoma cells in part
through SLC7A11 mediated ferroptosis. Biochem Biophys Res Commun.
567:118–124. 2021. View Article : Google Scholar
|
|
110
|
Cao JY and Dixon SJ: Mechanisms of
ferroptosis. Cell Mol Life Sci. 73:2195–2209. 2016. View Article : Google Scholar
|
|
111
|
Johnstone TC, Suntharalingam K and Lippard
SJ: The next generation of platinum drugs: Targeted Pt(II) agents,
nanoparticle delivery, and Pt(IV) prodrugs. Chem Rev.
116:3436–3486. 2016. View Article : Google Scholar
|
|
112
|
Kontoghiorghes GJ: New iron metabolic
pathways and chelation targeting strategies affecting the treatment
of all types and stages of cancer. Int J Mol Sci. 23:139902022.
View Article : Google Scholar
|
|
113
|
Chen X, Li J, Kang R, Klionsky DJ and Tang
D: Ferroptosis: Machinery and regulation. Autophagy. 17:2054–2081.
2021. View Article : Google Scholar
|
|
114
|
Yang W, Mu B, You J, Tian C, Bin H, Xu Z,
Zhang L, Ma R, Wu M, Zhang G, et al: Non-classical ferroptosis
inhibition by a small molecule targeting PHB2. Nat Commun.
13:74732022. View Article : Google Scholar
|
|
115
|
Zhang C, Liu J, Xu D, Zhang T, Hu W and
Feng Z: Gain-of-function mutant p53 in cancer progression and
therapy. J Mol Cell Biol. 12:674–687. 2020. View Article : Google Scholar
|
|
116
|
Hanson RL and Batchelor E: Coordination of
MAPK and p53 dynamics in the cellular responses to DNA damage and
oxidative stress. Mol Syst Biol. 18:e114012022. View Article : Google Scholar
|
|
117
|
Zhang C, Liu X, Jin S, Chen Y and Guo R:
Ferroptosis in cancer therapy: A novel approach to reversing drug
resistance. Mol Cancer. 21:472022. View Article : Google Scholar
|
|
118
|
Lei S, Cao W, Zeng Z, Zhang Z, Jin B, Tian
Q, Wu Y, Zhang T, Li D, Hu C, et al: JUND/linc00976 promotes
cholangiocarcinoma progression and metastasis, inhibits ferroptosis
by regulating the miR-3202/GPX4 axis. Cell Death Dis. 13:9672022.
View Article : Google Scholar
|
|
119
|
Ma S, Ma Y, Qi F, Lei J, Chen F, Sun W,
Wang D, Zhou S, Liu Z, Lu Z and Zhang D: HSDL2 knockdown promotes
the progression of cholangiocarcinoma by inhibiting ferroptosis
through the P53/SLC7A11 axis. World J Surg Oncol. 21:2932023.
View Article : Google Scholar
|
|
120
|
Shi X, Yang J, Wang M, Xia L, Zhang L and
Qiao S: Hsa_circ_0050900 affects ferroptosis in intrahepatic
cholangiocarcinoma cells by targeting hsa-miR-605-3p to regulate
SLC3A2. Oncol Lett. 27:22024. View Article : Google Scholar
|
|
121
|
Kaida T, Beppu T, Hayashi H, Imai K,
Yamamura K, Okabe H, Matsumura K, Yoshii D, Komohara Y, Akahoshi S,
et al: Inflammatory liver tumor caused by fasciola hepatica
mimicking intrahepatic cholangiocarcinoma. Anticancer Res.
40:2795–2800. 2020. View Article : Google Scholar
|
|
122
|
Agostinis P, Berg K, Cengel KA, Foster TH,
Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel
D, et al: Photodynamic therapy of cancer: An update. CA Cancer J
Clin. 61:250–281. 2011. View Article : Google Scholar
|
|
123
|
Zhang ZJ, Huang YP, Li XX, Liu ZT, Liu K,
Deng XF, Xiong L, Zou H and Wen Y: A novel ferroptosis-related
4-gene prognostic signature for cholangiocarcinoma and photodynamic
therapy. Front Oncol. 11:7474452021. View Article : Google Scholar
|
|
124
|
Gonzalez-Carmona MA, Bolch M, Strassburg
CP and Weismuller TJ: Editorial: Shining a light on
cholangiocarcinoma-a new dawn for photodynamic therapy? Authors'
reply. Aliment Pharmacol Ther. 49:953–954. 2019. View Article : Google Scholar
|
|
125
|
Du J, Wan Z, Wang C, Lu F, Wei M, Wang D
and Hao Q: Designer exosomes for targeted and efficient ferroptosis
induction in cancer via chemo-photodynamic therapy. Theranostics.
11:8185–8196. 2021. View Article : Google Scholar
|
|
126
|
Yan X, Li Z, Chen H, Yang F, Tian Q and
Zhang Y: Photodynamic therapy inhibits cancer progression and
induces ferroptosis and apoptosis by targeting P53/GPX4/SLC7A11
signaling pathways in cholangiocarcinoma. Photodiagnosis Photodyn
Ther. 47:1041042024. View Article : Google Scholar
|
|
127
|
Huang YP, Wang YX, Zhou H, Liu ZT, Zhang
ZJ, Xiong L, Zou H and Wen Y: Surufatinib combined with
photodynamic therapy induces ferroptosis to inhibit
cholangiocarcinoma in vitro and in tumor models. Front Pharmacol.
15:12882552024. View Article : Google Scholar
|
|
128
|
Ingle J and Basu S: Mitochondria targeted
AIE probes for cancer phototherapy. ACS Omega. 8:8925–8935. 2023.
View Article : Google Scholar
|
|
129
|
Kojima Y, Tanaka M, Sasaki M, Ozeki K,
Shimura T, Kubota E and Kataoka H: Induction of ferroptosis by
photodynamic therapy and enhancement of antitumor effect with
ferroptosis inducers. J Gastroenterol. 59:81–94. 2024. View Article : Google Scholar
|
|
130
|
Wang P, Hu Z, Yu S, Su S, Wu R, Chen C, Ye
Y, Wang H, Ye X, Zhou Z, et al: A novel protein encoded by
circFOXP1 enhances ferroptosis and inhibits tumor recurrence in
intrahepatic cholangiocarcinoma. Cancer Lett. 598:2170922024.
View Article : Google Scholar
|
|
131
|
Zhang Z, Akuetteh PD, Lin L, Wu Y, Li Y,
Huang W, Ni H, Lv H and Zhang Q: Development and validation of a
ferroptosis-related model for three digestive tract tumors based on
a pan-cancer analysis. Epigenomics. 13:1497–1514. 2021. View Article : Google Scholar
|
|
132
|
Sae-Fung A, Mutirangura A and Jitkaew S:
Identification and validation of a novel ferroptosis-related gene
signature for prognosis and potential therapeutic target prediction
in cholangiocarcinoma. Front Immunol. 13:10512732022. View Article : Google Scholar
|
|
133
|
Yao X, Chen B, Wang M, Zhang S, He B, Shi
Z, Deng T, Bao W, Wang Y, Chen G and Bo Z: Exploration and
validation of a novel ferroptosis-related gene signature predicting
the prognosis of intrahepatic cholangiocarcinoma. Acta Biochim
Biophys Sin (Shanghai). 54:1376–1385. 2022.
|
|
134
|
Wang Z, Zhang Y, Chen Y, Liu S, Li C and
Li X: Identification of a ferroptosis-related gene signature for
predicting the prognosis of cholangiocarcinoma. Expert Rev
Gastroenterol Hepatol. 16:181–191. 2022. View Article : Google Scholar
|
|
135
|
Liu S, Fan S, Wang Y, Chen R, Wang Z,
Zhang Y, Jiang W, Chen Y, Xu X, Yu Y, et al: ACSL4 serves as a
novel prognostic biomarker correlated with immune infiltration in
Cholangiocarcinoma. BMC Cancer. 23:4442023. View Article : Google Scholar
|
|
136
|
Hori Y, Yoh T, Nishino H, Okura K,
Kurimoto M, Takamatsu Y, Satoh M, Nishio T, Koyama Y, Ishii T, et
al: Ferroptosis-related gene glutathione peroxidase 4 promotes
reprogramming of glucose metabolism via Akt-mTOR axis in
intrahepatic cholangiocarcinoma. Carcinogenesis. 45:119–130. 2023.
View Article : Google Scholar
|
|
137
|
Xu L, Gao X, Xing J and Guo Z:
Identification of a necroptosis-related gene signature as a novel
prognostic biomarker of cholangiocarcinoma. Front Immunol.
14:11188162023. View Article : Google Scholar
|
